HIAS Postdoctoral Researcher, Hitotsubashi Institute for Advanced Study, Hitotsubashi University
Thomas Rouyard holds an M.Sc. in Economics from the Paris School of Economics, France, and a Ph.D. in Population Health from the University of Oxford, UK. His research interests lie in the area of global health, including theoretical and empirical work to inform the design of health-related interventions and policies. In particular, he is interested in using insights from behavioural economics to explore new approaches to improve the prevention and management of lifestyle-related diseases. Before joining HIAS in June 2019, Thomas was a Doctoral Transition Fellow supported by the European Institute for Innovation and Technology(EIT) at the University of Oxford.
Detailed profile (HRI: Hitotsubashi Researchers Information)
- Rouyard T, Leal J, Salvi D, et al. An Intuitive Risk Communication Tool to Enhance Patient–Provider Partnership in Diabetes Consultation. J Diabetes Sci Technol 2021; 1932296821995800.
- Dieterich AV, Müller AM, Akksilp K, et al. Reducing sedentary behaviour and physical inactivity in the workplace: protocol for a review of systematic reviews. BMJ Open Sport Exerc Med 2020; 6(1), e000909.
- Chen C, Dieterich AV, Koh JJE, et al. The physical activity at work (PAW) study protocol: a cluster randomised trial of a multicomponent short-break intervention to reduce sitting time and increase physical activity among office workers in Thailand. BMC Public Health 2020; 20(1), 1-12.
- Rouyard T, Attema A, Baskerville R, et al. Risk attitudes of people with ‘manageable’ chronic disease: an analysis under prospect theory. Soc Sci Med 2018; 214, 144-153.
- Rouyard T, Leal J, Baskerville R, et al. Nudging people with Type 2 diabetes towards better self‐management through personalized risk communication: A pilot randomized controlled trial in primary care. Endocrinol Diabetes Metab 2018; 1(3), e00022.
- Rouyard T, Kent S, Baskerville R, et al. Perceptions of risks for diabetes-related complications in Type 2 diabetes populations: a systematic review. Diabet Med 2017; 34(4), 467-477.